The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios
Crossref DOI link: https://doi.org/10.1007/s00259-016-3497-z
Published Online: 2016-08-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Basu, Sandip
Ostwal, Vikas
License valid from 2016-08-20